Should chemotherapy still be used to treat all muscle invasive bladder cancer in the “era of immunotherapy”?

Jonathan J. Duplisea; Colin P.N. Dinney

doi:10.1080/14737140.2019.1625773

Should chemotherapy still be used to treat all muscle invasive bladder cancer in the “era of immunotherapy”?

Jonathan J. Duplisea, Colin P.N. Dinney

Urology

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	543-545
Number of pages	3
Journal	Expert review of anticancer therapy
Volume	19
Issue number	7
DOIs	https://doi.org/10.1080/14737140.2019.1625773
State	Published - Jul 3 2019

Keywords

Muscle invasive bladder cancer
chemotherapy
immunotherapy

ASJC Scopus subject areas

Oncology
Pharmacology (medical)

Access to Document

10.1080/14737140.2019.1625773

Cite this

@article{dacd07ce77434c558efdf7f981b084b7,

title = "Should chemotherapy still be used to treat all muscle invasive bladder cancer in the “era of immunotherapy”?",

keywords = "Muscle invasive bladder cancer, chemotherapy, immunotherapy",

author = "Duplisea, {Jonathan J.} and Dinney, {Colin P.N.}",

year = "2019",

month = jul,

day = "3",

doi = "10.1080/14737140.2019.1625773",

language = "English (US)",

volume = "19",

pages = "543--545",

journal = "Expert review of anticancer therapy",

issn = "1473-7140",